These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33179893)

  • 21. [Monitoring post-prandial blood sugars in the diabetic patient].
    Boche S; Bouffard S
    Rev Infirm; 2010 Nov; (165):40-2. PubMed ID: 21121170
    [No Abstract]   [Full Text] [Related]  

  • 22. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
    Heinemann L; Freckmann G; Müller-Wieland D; Kellerer M
    J Diabetes Sci Technol; 2020 Sep; 14(5):922-927. PubMed ID: 31675907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (6) Glycemic targets.
    American Diabetes Association
    Diabetes Care; 2015 Jan; 38 Suppl():S33-40. PubMed ID: 25537705
    [No Abstract]   [Full Text] [Related]  

  • 24. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycaemic variability in diabetes: clinical and therapeutic implications.
    Ceriello A; Monnier L; Owens D
    Lancet Diabetes Endocrinol; 2019 Mar; 7(3):221-230. PubMed ID: 30115599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The gluco-phenotype.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2016 Jan; 66(1):118-9. PubMed ID: 26712197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Frequency of Technology Uploads on Glycemic Control in Adult Insulin Pump Users.
    Gannon S; O'Keeffe D; O'Sullivan E
    J Diabetes Sci Technol; 2021 Mar; 15(2):519-520. PubMed ID: 32856496
    [No Abstract]   [Full Text] [Related]  

  • 28. Managing your blood glucose ups and downs.
    Griffin S; Ballard D
    Diabetes Self Manag; 2009; 26(1):36, 38, 41-2 passim. PubMed ID: 19213144
    [No Abstract]   [Full Text] [Related]  

  • 29. Effective diabetes education in the home care setting.
    Haney PM
    Home Care Provid; 2001 Feb; 6(1):20-9; quiz 30-1. PubMed ID: 11174326
    [No Abstract]   [Full Text] [Related]  

  • 30. Dispelling myths and removing barriers about insulin in type 2 diabetes.
    Meece J
    Diabetes Educ; 2006; 32(1 Suppl):9S-18S. PubMed ID: 16439485
    [No Abstract]   [Full Text] [Related]  

  • 31. Estimated average glucose derived from HbA1c eAG: report from European Association for the Study of Diabetes (EASD), Amsterdam 2007.
    Manley SE
    Diabet Med; 2008 Feb; 25(2):126-8. PubMed ID: 18290854
    [No Abstract]   [Full Text] [Related]  

  • 32. Intensive diabetes management: implications of the DCCT and UKPDS.
    American Association of Diabetes Educators
    Diabetes Educ; 2002; 28(5):735-40. PubMed ID: 14625959
    [No Abstract]   [Full Text] [Related]  

  • 33. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2020 Feb; 22(S1):S32-S46. PubMed ID: 32069160
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method.
    Bruttomesso D; Laviola L; Avogaro A; Bonora E; Del Prato S; Frontoni S; Orsi E; Rabbone I; Sesti G; Purrello F;
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):421-431. PubMed ID: 30952574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support.
    Klonoff DC
    J Diabetes Sci Technol; 2012 May; 6(3):486-90. PubMed ID: 22768877
    [No Abstract]   [Full Text] [Related]  

  • 36. New insulins and insulin therapy.
    Danne T; Bolinder J
    Diabetes Technol Ther; 2013 Feb; 15 Suppl 1():S40-7. PubMed ID: 23441707
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of glycaemic control in patients with diabetes mellitus on insulin therapy.
    Mukherjee JJ; Majumdar S; Ray S
    J Indian Med Assoc; 2013 Nov; 111(11):761-5. PubMed ID: 24968486
    [No Abstract]   [Full Text] [Related]  

  • 38. Advances in Type 2 Diabetes: Focus on Basal Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy.
    Shubrook JH
    J Fam Pract; 2018 Aug; 67(8 suppl):S49-S54. PubMed ID: 30137054
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of glycemic control in diabetes in the CVOT era.
    Einhorn D
    J Diabetes; 2020 Jan; 12(1):4. PubMed ID: 31746129
    [No Abstract]   [Full Text] [Related]  

  • 40. Guidelines for glycemic control.
    Clement S
    Clin Cornerstone; 2004; 6(2):31-9. PubMed ID: 15628691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.